CMAC 2006; 8(4) | CMAC

CMAC 2006; 8(4)

Over the last years there is an increase in number of publications that address to the failure of empirical therapy of anaerobic …
Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(4):298-313
PDF

Tumor necrosis factor (TNF)-blocking agents are one of the new option in the treatment of immune-mediated inflammatory diseases, such …
Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(4):314-324
PDF

Carpabenems (imipenem, meropenem, ertapenem) are currently one of the antibiotic classes that exhibit the broadest spectrum of activity …
Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(4):325-349
PDF

Azithromycin is one of the most commonly used macrolides in the treatment of respiratory tract infections. Azithromycin is a popular …
Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(4):350-358
PDF

Two groups of children on therapy with monofluoroquinolones were enrolled in this open trial: 169 patients with cystic fibrosis …
Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(4):359-367
PDF

Beta-lactams remain the most used class of antibiotics all over the world. Among them, cephalosporins occupy the leading place. This is …
Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(4):368-382
PDF

Invasive aspergillosis is a common complication in children with hemoblastosis. This type of mycosis characterized with severe clinical …
Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(4):383-388
PDF